The NLNK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NLNK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NLNK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NLNK Detailed Price Forecast - CNN Money||View NLNK Detailed Summary - Google Finance|
|View NLNK Detailed Summary - Yahoo! Finance||View NLNK Stock Research & Analysis - Zacks.com|
|View NLNK Trends & Analysis - Trade-Ideas||View NLNK Major Holders - Barrons|
|View NLNK Call Transcripts - NASDAQ||View NLNK Breaking News & Analysis - Seeking Alpha|
|View NLNK Annual Report - CompanySpotlight.com||View NLNK OTC Short Report - OTCShortReport.com|
|View NLNK Fundamentals - TradeKing||View NLNK SEC Filings - Bar Chart|
|View Historical Prices for NLNK - The WSJ||View Performance/Total Return for NLNK - Morningstar|
|View the Analyst Estimates for NLNK - MarketWatch||View the Earnings History for NLNK - CNBC|
|View the NLNK Earnings - StockMarketWatch||View NLNK Buy or Sell Recommendations - MacroAxis|
|View the NLNK Bullish Patterns - American Bulls||View NLNK Short Pain Metrics - ShortPainBot.com|
|View NLNK Stock Mentions - StockTwits||View NLNK Stock Mentions - PennyStockTweets|
|View NLNK Stock Mentions - Twitter||View NLNK Investment Forum News - Investor Hub|
|View NLNK Stock Mentions - Yahoo! Message Board||View NLNK Stock Mentions - Seeking Alpha|
|View Insider Transactions for NLNK - SECform4.com||View Insider Transactions for NLNK - Insider Cow|
|View NLNK Major Holdings Summary - CNBC||View Insider Disclosure for NLNK - OTC Markets|
|View Insider Transactions for NLNK - Yahoo! Finance||View Institutional Holdings for NLNK - NASDAQ|
|View NLNK Stock Insight & Charts - FinViz.com||View NLNK Investment Charts - StockCharts.com|
|View NLNK Stock Overview & Charts - BarChart||View NLNK User Generated Charts - Trading View|
Complimentary Technical Snapshots on OHR Pharma and Three More Biotech Stocks
Posted on Friday July 13, 2018
LONDON, UK / ACCESSWIRE / July 13, 2018 / If you want a free Stock Review on OHRP sign up now at www.wallstequities.com/registration. For today, WallStEquities.com observes Auris Medical Holding AG (EARS), NewLink Genetics Corp. (NLNK), OHR Pharmaceutical Inc. (OHRP), and Omeros Corp. (OMER). The industry includes the manufacturing and marketing of drugs as a result of direct research and development.
NewLink Genetics to Host Its Second Quarter 2018 Financial Results Conference Call on July 31, 2018
Posted on Tuesday July 10, 2018
AMES, Iowa, July 10, 2018-- NewLink Genetics Corporation today announced that it will release its second quarter 2018 financial results on Tuesday, July 31, 2018. The company has scheduled a conference ...
NewLink Genetics Corporation (NLNK), reported that updated Phase 1 data evaluating indoximod plus front-line radiation and maintenance chemotherapy for the treatment of pediatric patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG) were presented Sunday, July 1, at the International Symposium of Pediatric Neuro-Oncology (ISPNO) 2018 Annual Meeting in Denver. Data were presented on ten newly diagnosed DIPG patients, all of whom had initiated therapy at the time of this assessment. “These data continue to demonstrate the potential for indoximod plus radiochemotherapy as a combination treatment regimen which may improve disease related symptoms for these pediatric patients with an otherwise dire prognosis,” said Dr. Theodore S. Johnson, M.D., Ph.D., Associate Professor of Pediatrics at Augusta University, lead investigator for the trial.
The Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus
Posted on Saturday June 30, 2018
Biotech stocks came under pressure earlier in the week, weighed down by negative trial results, mixed FDA verdicts and overall pessimistic broader market sentiment, but recovered in the last two sessions. ...